Grape Drink Trial for Diabetes and Fatty Liver
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests a drink made from grape pomace (a natural byproduct) that is rich in polyphenols—compounds that may help the liver and heart. Participants have type 2 diabetes and mild fatty liver, and researchers want to see if the drink improves liver health, blood sugar, and gut bacteria over several months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your BMI (body mass index) should be over 25 but not over 35.
- Your total cholesterol must be 250 or lower, and your triglycerides 200 or lower.
- You have type 2 diabetes that is well controlled (HbA1c at or below 7.5%) and you manage it with diet alone or diet plus metformin only (no insulin or other diabetes drugs).
- You have not had a heart attack or stroke.
- You do not have kidney or liver problems, anemia, or any other chronic disease.
- You do not do regular intense exercise.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a specific medical nutrition therapy diet to see if it can reduce liver fat and improve blood sugar control in people with type 2 diabetes and nonalcoholic fatty liver disease. It may help you manage both conditions with a dietary approach.
This study looks at how the liver uses energy (mitochondria) in people with type 2 diabetes and fatty liver disease. By understanding this, researchers may find better ways to treat liver problems.
This study tests a food supplement that could help people with higher than normal blood sugar, but not yet diabetes. The goal is to see if it can improve blood sugar levels and insulin resistance.
This study looks at how the body handles a sugar called fructose in people with and without fatty liver disease. It aims to understand how fructose contributes to liver fat buildup.
This trial tests if a plant-based diet can improve liver health and reduce exposure to harmful chemicals in people with metabolic liver disease. It may help you improve your liver biomarkers and overall cardiometabolic health.
This trial tests whether taking a daily drink containing short-chain fatty acids can improve risk factors for metabolic syndrome, like belly fat, high blood sugar, or high blood pressure. It might help if you are at risk but not yet taking medications for these conditions.
Hear when a new Diabetes Mellitus Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.